Dr. Michele Graciotti is Director of Clinical Development at Swiss Medical Network, one of Switzerland’s largest groups of private hospitals. In this role, his mission is to drive innovation and translate promising scientific discoveries into novel therapies and medical approaches that ultimately benefit patients.
Prior to joining Swiss Medical Network, Dr. Graciotti worked in clinical trial coordination within the Department of Oncology at the University Hospital of Lausanne (CHUV), gaining extensive experience in the clinical development of innovative treatments.
Dr. Graciotti holds a PhD in Cell Physiology and Pharmacology from the University of Leicester, UK. He has longstanding experience across drug discovery, product development, and GMP manufacturing, with a particular focus on malaria and cancer immunotherapy. His career bridges fundamental research, translational medicine, and clinical development, with a strong commitment to bringing innovative medical solutions from the laboratory to patients.